4-Bromo-1,5-naphthyridine, 95+%, 1g

1,2-Ethanediamine, N1-methyl-N1-[[4-[4-(1-methylethoxy)phenyl]-1H-pyrrol-3-yl]methyl]-, 98%, 100mg

3-Fluoro-4-(trifluoromethoxy)benzoic acid, 95.0%, 5g

3-propylthieno[3,2-d]pyrimidine-2,4(1H,3H)-dione, 250mg

1,3-Dichloro-2-iodobenzene>98.0%(GC)25g

Unità filtro centrifuga Ultrafree Ultrafree-MC, membrana in PVDF, volume del campione fino a 0,5 ml, 5,0 µm, non sterile, 100 Pezzo(i)

5-Bromo-2-methyl-1H-benzo[d]imidazole, 95.0%, 10g

2-amino-1-(1H-indol-3-yl)ethanone hydrochloride, 95.0%, 100mg

4-Cyano-3-(5,5-Dimethyl-[1,3,2]dioxaborinan-2-yl)-pyridine, 98+%, 5g

6-(Difluoromethyl)nicotinonitrile, 97%, 1g

Isobutyl cinnamate, 95.0%, 5g

2-Cyanoethyl Acrylate (stabilized with MEHQ)>95.0%(GC)25g

3-Bromo-2-chloroisonicotinic acid, 97%, 1g